Akari Therapeutics (AKTX) Prepaid Assets (2014 - 2026)
Akari Therapeutics recorded quarterly Prepaid Assets of $731000.0 in Q1 2026, up 5121.43% quarter-over-quarter from $14000.0 in Q4 2025, and up 813.75% year-over-year from $80000.0 in Q1 2025.
Akari Therapeutics' Prepaid Assets history runs 13 years deep, the most recent figure standing at $731000.0 for Q1 2026.
- In Q1 2026, Prepaid Assets rose 813.75% year-over-year to $731000.0; the TTM figure through Mar 2026 stood at $731000.0 (up 813.75% YoY), while the FY2025 annual figure was $14000.0, down 84.78% from the prior year.
- Prepaid Assets came in at $731000.0 for Q1 2026 at Akari Therapeutics, up from $14000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $805000.0 in Q2 2024 to a low of -$442851.0 in Q1 2022.
- A 5-year average of $185235.6 and a median of $87500.0 in 2024 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets slumped 249.72% in 2023 and jumped 1025.51% in 2024, its largest moves.
- Akari Therapeutics' Prepaid Assets stood at $465000.0 in 2022, then sank by 57.63% to $197000.0 in 2023, then sank by 53.3% to $92000.0 in 2024, then tumbled by 84.78% to $14000.0 in 2025, then soared by 5121.43% to $731000.0 in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $731000.0, $14000.0, and $53000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 731,000.00 |
| Dec 31, 2025 | 185,000.00 |
| Sep 30, 2025 | 349,000.00 |
| Jun 30, 2025 | 447,000.00 |
| Mar 31, 2025 | 80,000.00 |
| Dec 31, 2024 | 201,000.00 |
| Sep 30, 2024 | 396,000.00 |
| Jun 30, 2024 | 805,000.00 |
| Mar 31, 2024 | 232,000.00 |
| Dec 31, 2023 | 197,000.00 |
| Jun 30, 2023 | 186,566.00 |
| Dec 31, 2022 | 465,000.00 |
| Jun 30, 2022 | -24,871.00 |
| Mar 31, 2022 | -442,851.00 |
| Dec 31, 2021 | 90,301.00 |
| Sep 30, 2021 | -782.14 Bn |
| Jun 30, 2021 | 1.01 Mn |
| Mar 31, 2021 | 1.14 Mn |
| Dec 31, 2020 | 229,200.00 |
| Sep 30, 2020 | 1.35 Mn |
| Jun 30, 2020 | 1.68 Mn |
| Mar 31, 2020 | -1,115.33 Bn |
| Dec 31, 2019 | 712,975.00 |
| Sep 30, 2019 | 1.06 Mn |
| Jun 30, 2019 | 1.75 Mn |
| Mar 31, 2019 | -464,696.00 |
| Dec 31, 2018 | 1.42 Mn |
| Sep 30, 2018 | 1.38 Mn |
| Jun 30, 2018 | -747,101.00 |
| Mar 31, 2018 | 1.48 Mn |
| Dec 31, 2017 | 706,415.00 |
| Sep 30, 2017 | 1.22 Mn |
| Jun 30, 2017 | -172,022.00 |
| Mar 31, 2017 | 1.34 Mn |
| Dec 31, 2016 | 1.51 Mn |
| Sep 30, 2016 | -457,864.00 |
| Jun 30, 2016 | 1.58 Mn |
| Mar 31, 2016 | 1.25 Mn |
| Dec 31, 2015 | 728,126.00 |
| Sep 30, 2015 | 1.48 Mn |
| Jun 30, 2015 | -112,610.00 |
| Dec 31, 2014 | 7,781.00 |